drugset / Trial / NCT00652301

A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

NCT00652301

Phase 3 Completed 40 enrolled Organon and Co Schering-Plough · collab
RandomizedCrossoverDouble-blindDiagnostic

Summary

To determine the effect of ezetimibe and simvastatin given together, and ezetimibe and simvastatin given alone on intestinal cholesterol absorption.

Timeline

Start
2003-07
Primary completion
2004-04
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg
Subject Simvastatin Small molecule 20 mg

Indications

No indication recorded.